Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2020
Market Capitalization	176,738	112,466	401,663	-	-	-	Upgrade
Market Cap Growth	27.28%	-72.00%	-	-	-	-	Upgrade
Enterprise Value	199,469	132,063	415,683	-	-	-	Upgrade
Last Close Price	22.00	14.00	50.00	-	-	-	Upgrade
PE Ratio	-	1455.37	84.18	-	-	-	Upgrade
PS Ratio	18.74	6.66	18.29	-	-	-	Upgrade
PB Ratio	0.62	0.39	1.40	-	-	-	Upgrade
P/TBV Ratio	0.62	0.39	1.40	-	-	-	Upgrade
EV/Sales Ratio	21.15	7.82	18.93	-	-	-	Upgrade
EV/EBITDA Ratio	-	124.80	71.77	-	-	-	Upgrade
EV/EBIT Ratio	-	168.41	72.97	-	-	-	Upgrade
Debt / Equity Ratio	0.08	0.08	0.05	0.07	0.09	0.07	Upgrade
Debt / EBITDA Ratio	-	21.26	2.42	0.69	1.71	-	Upgrade
Asset Turnover	0.03	0.05	0.08	0.13	0.10	0.02	Upgrade
Inventory Turnover	0.07	0.12	0.21	0.39	0.30	0.06	Upgrade
Quick Ratio	0.19	0.46	0.95	0.04	0.04	0.02	Upgrade
Current Ratio	4.82	5.15	4.72	0.33	0.36	0.32	Upgrade
Return on Equity (ROE)	-1.09%	0.03%	2.30%	9.62%	4.33%	-5.67%	Upgrade
Return on Assets (ROA)	-0.49%	0.15%	1.21%	3.02%	1.42%	-1.02%	Upgrade
Return on Capital (ROIC)	-0.51%	0.16%	1.62%	6.30%	3.15%	-1.67%	Upgrade
Return on Capital Employed (ROCE)	-	0.30%	1.90%	9.60%	4.80%	-	Upgrade
Earnings Yield	-1.78%	0.07%	1.19%	-	-	-	Upgrade
Buyback Yield / Dilution	9.37%	0.00%	-25.06%	-	-180.45%	-281.98%	Upgrade

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.